This article gives an extensive Assessment of the security risks related to gray-market peptides, regulatory frameworks governing their use, and evidence-primarily based direction for Health care suppliers and shoppers navigating this complicated landscape. U.S. peptide imports from China nearly doubled in 2025, reaching $328 million in the main nine months https://jessicah813iig4.wiki-cms.com/user